Regulatory Status
The CTLM® is not approved for sale in the USA. To qualify for permission to sell and market, IDSI must obtain United States Food and Drug Administration marketing clearance. An FDA submission is supported by extensive data, including pre-clinical and clinical trial data, as well as extensive literature to prove the safety and effectiveness of the device.
The company has received ISO 13485 certification.
